Sonova Holding (OTCMKTS:SONVY) Receives Average Recommendation of “Moderate Buy” from Analysts

Sonova Holding (OTCMKTS:SONVY) has been given a consensus rating of “Moderate Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, one has issued a buy recommendation and two have issued a strong buy recommendation on the company.

Several research firms have recently weighed in on SONVY. Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Finally, BNP Paribas Exane raised Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th.

Sonova Stock Down 2.1%

Shares of SONVY stock opened at $44.67 on Friday. Sonova has a 12-month low of $44.49 and a 12-month high of $68.76. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The firm has a 50-day moving average price of $52.03 and a 200 day moving average price of $53.21.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.